Home The Word Brain My Amedeo FAQ Privacy About   


2049 Chinese

The 20K Word Road to Mandarin Proficiency

By B. S. Kamps et al.


  Rheumatoid Arthritis

  Free Subscription


26.02.2024

9 Ann Rheum Dis
1 Arthritis Res Ther
1 Clin Exp Immunol
5 Clin Exp Rheumatol
1 Clin Orthop Relat Res
7 Clin Rheumatol
3 Lancet
2 PLoS One
1 Rheumatol Int
5 Z Rheumatol


  Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    Ann Rheum Dis

  1. VAN DER WOUDE D, Toes REM
    Immune response to post-translationally modified proteins in rheumatoid arthritis: what makes it special?
    Ann Rheum Dis. 2024 Feb 20:ard-2023-224103. doi: 10.1136/ard-2023-224103.
    PubMed         Abstract available

  2. TANG Z, Shi H, Liu HL, Cheng X, et al
    Correspondence on '2023 ACR/EULAR antiphospholipid syndrome classification criteria'.
    Ann Rheum Dis. 2024;83:e4.
    PubMed        

  3. BARBHAIYA M, Zuily S, Hendry AM, Manneville F, et al
    Response to: Correspondence on '2023 ACR/EULAR antiphospholipid syndrome classification criteria' by Tang et al.
    Ann Rheum Dis. 2024;83:e5.
    PubMed        

  4. DAMOISEAUX J, van Beers J
    Correspondence on "ACR/EULAR antiphospholipid syndrome classification criteria".
    Ann Rheum Dis. 2024;83:e6.
    PubMed        

  5. ERKAN D, Barbhaiya M, Zuily S, Bertolaccini ML, et al
    Response to: Correspondence on '2023 ACR/EULAR antiphospholipid syndrome classification criteria' by Miro-Mur et al.
    Ann Rheum Dis. 2024;83:e3.
    PubMed        

  6. BARBHAIYA M, Zuily S, Bertolaccini ML, Willis R, et al
    Response to: Correspondence on 'ACR/EULAR antiphospholipid syndrome classification criteria' by Damoiseaux and van Beers.
    Ann Rheum Dis. 2024;83:e7.
    PubMed        

  7. MIRO-MUR FA, Alijotas-Reig J, Anunciacion-Llunell A, Marques-Soares J, et al
    Correspondence on '2023 ACR/EULAR antiphospholipid syndrome classification criteria'.
    Ann Rheum Dis. 2024;83:e2.
    PubMed        

  8. PEZOT M, Nocturne G, Belkhir R, Henry J, et al
    Obinutuzumab in patients with Sjogren's disease immunised against rituximab.
    Ann Rheum Dis. 2024;83:407-408.
    PubMed        

  9. DORNER T, Kaul M, Szanto A, Tseng JC, et al
    Efficacy and safety of remibrutinib, a selective potent oral BTK inhibitor, in Sjogren's syndrome: results from a randomised, double-blind, placebo-controlled phase 2 trial.
    Ann Rheum Dis. 2024;83:360-371.
    PubMed         Abstract available


    Arthritis Res Ther

  10. LI G, Fang Y, Xu N, Ding Y, et al
    Fibroblast-like synoviocytes-derived exosomal circFTO deteriorates rheumatoid arthritis by enhancing N6-methyladenosine modification of SOX9 in chondrocytes.
    Arthritis Res Ther. 2024;26:56.
    PubMed         Abstract available


    Clin Exp Immunol

  11. IWAI T, Ohyama A, Osada A, Nishiyama T, et al
    Role of inter-alpha-trypsin inhibitor heavy chain 4 and its citrullinated form in experimental arthritis murine models.
    Clin Exp Immunol. 2024;215:302-312.
    PubMed         Abstract available


    Clin Exp Rheumatol

  12. KHULLAR A, Dhir V, Saikia B, Yadav AK, et al
    Rheumatoid arthritis synovial fluid shows enrichment of T-cells producing GMCSF which are polyfunctional for TNFalpha and IFNgamma.
    Clin Exp Rheumatol. 2024 Feb 12. doi: 10.55563.
    PubMed         Abstract available

  13. CEN X, Chen Y, Liu H, Luo Y, et al
    Methotrexate inhibits LPS-induced glycolysis in fibroblast-like synoviocytes isolated from patients with rheumatoid arthritis.
    Clin Exp Rheumatol. 2024 Feb 6. doi: 10.55563.
    PubMed        

  14. FEDERICO JA, Syvaranta SA, Tuohinen SS, Holmstrom MM, et al
    Myocardial T1 mapping by cardiac magnetic resonance imaging shows early myocardial changes in treatment-naive patients with active rheumatoid arthritis and positive autoantibodies.
    Clin Exp Rheumatol. 2024 Feb 6. doi: 10.55563.
    PubMed         Abstract available

  15. ALP G, Cinakli H, Kurut Aysin I, Solmaz D, et al
    Challenges and insights in managing difficult-to-treat rheumatoid arthritis: real-world clinical perspectives.
    Clin Exp Rheumatol. 2024 Jan 31. doi: 10.55563.
    PubMed         Abstract available

  16. GUO N, Li X, Movahedi M, Cesta A, et al
    Biologics initiation in moderate versus severe rheumatoid arthritis: real-world experience from a Canadian registry.
    Clin Exp Rheumatol. 2024 Jan 31. doi: 10.55563.
    PubMed         Abstract available


    Clin Orthop Relat Res

  17. WALTER N, Szymski D, Kurtz SM, Alt V, et al
    What Are the Mortality, Infection, and Nonunion Rates After Periprosthetic Femoral Fractures in the United States?
    Clin Orthop Relat Res. 2023 Sep 5. doi: 10.1097/CORR.0000000000002825.
    PubMed         Abstract available


    Clin Rheumatol

  18. PHAM C, Niu F, Hui RL, Le KN, et al
    Patient perceptions on switching from reference product adalimumab to biosimilar adalimumab-atto.
    Clin Rheumatol. 2024;43:1269-1270.
    PubMed        

  19. ESPINOSA-BAUTISTA F, Salazar-Sanchez MI, Brianza-Padilla M, Leon-Avila G, et al
    Dysregulation of long non-coding RNAs in Takayasu arteritis: A proof-of-concept study.
    Clin Rheumatol. 2024;43:1253-1259.
    PubMed         Abstract available

  20. BAO X
    Validation of new immune and inflammation-related diagnostic biomarkers for RA.
    Clin Rheumatol. 2024;43:949-958.
    PubMed         Abstract available

  21. BOHMAN BR, Dowds HS, Blagogee TE, Ike RW, et al
    Sjogren's disease activity associates with cardiovascular disease and monoclonal gammopathy: a university cohort study of disease activity and comorbidities.
    Clin Rheumatol. 2024;43:1093-1101.
    PubMed         Abstract available

  22. SUZUKI S, Kataoka Y, Otani T, Taniguchi Y, et al
    Optimal time of starting tocilizumab in acute phase of adult-onset Still's disease and comparison of its efficacy with that of methotrexate: a case series and a review of the literature.
    Clin Rheumatol. 2024;43:1245-1251.
    PubMed         Abstract available

  23. WANG B, Liu J, Zhao L
    Association of congestive heart failure with mortality in individuals with rheumatoid arthritis: a cohort study.
    Clin Rheumatol. 2024 Feb 20. doi: 10.1007/s10067-024-06878.
    PubMed         Abstract available

  24. CHEN D, Zhang J
    Commentary on the factors with liver fibrosis in rheumatoid arthritis patients treated with methotrexate.
    Clin Rheumatol. 2024 Feb 23. doi: 10.1007/s10067-024-06896.
    PubMed        


    Lancet

  25. VAN DER HELM-VAN MIL AHM
    Abatacept in individuals with autoantibody-positive arthralgia at risk for rheumatoid arthritis.
    Lancet. 2024 Feb 14:S0140-6736(24)00055-2. doi: 10.1016/S0140-6736(24)00055.
    PubMed        

  26. RECH J, Tascilar K, Hagen M, Kleyer A, et al
    Abatacept inhibits inflammation and onset of rheumatoid arthritis in individuals at high risk (ARIAA): a randomised, international, multicentre, double-blind, placebo-controlled trial.
    Lancet. 2024 Feb 13:S0140-6736(23)02650-8. doi: 10.1016/S0140-6736(23)02650.
    PubMed         Abstract available

  27. COPE AP, Jasenecova M, Vasconcelos JC, Filer A, et al
    Abatacept in individuals at high risk of rheumatoid arthritis (APIPPRA): a randomised, double-blind, multicentre, parallel, placebo-controlled, phase 2b clinical trial.
    Lancet. 2024 Feb 13:S0140-6736(23)02649-1. doi: 10.1016/S0140-6736(23)02649.
    PubMed         Abstract available


    PLoS One

  28. BERGMANS B, Jessurun N, van Lint J, Murk JL, et al
    Burden of non-serious infections during biological use for rheumatoid arthritis.
    PLoS One. 2024;19:e0296821.
    PubMed         Abstract available

  29. DE ARAUJO BMM, de Miranda BM, Kowaltschuk TC, Goncalves FM, et al
    Impact of chronic diseases on the periapical health of endodontically treated teeth: A systematic review and meta-analysis.
    PLoS One. 2024;19:e0297020.
    PubMed         Abstract available


    Rheumatol Int

  30. SHARMA P, Brown S, Sokoya EM
    Re-evaluation of dietary interventions in rheumatoid arthritis: can we improve patient conversations around food choices?
    Rheumatol Int. 2024 Feb 20. doi: 10.1007/s00296-024-05541.
    PubMed         Abstract available


    Z Rheumatol

  31. SANDIKCI SC, Gultuna S, Ozisler C, Aydin FN, et al
    The role of orexin in fatigue and sleep quality in patients with primary Sjogren's syndrome.
    Z Rheumatol. 2024;83.
    PubMed         Abstract available

  32. FIEHN C, Leipe J, Weseloh C, Bergner R, et al
    Assessment of interactions and dosage recommendations of synthetic DMARDs-Evidence-based and consensus-based recommendations based on a systematic literature search.
    Z Rheumatol. 2024;83.
    PubMed         Abstract available

  33. SEIFERT O, Baerwald C
    Stimulation of the vagus nerve as a therapeutic principle.
    Z Rheumatol. 2024;83.
    PubMed         Abstract available

  34. ALBRECHT K, Binder S, Minden K, Poddubnyy D, et al
    Systematic review to estimate the prevalence of inflammatory rheumatic diseases in Germany.
    Z Rheumatol. 2024;83.
    PubMed         Abstract available

  35. ISIK AC, Kavas M, Tezcan ME
    Metabolic syndrome may be more frequent in treatment-naive sarcoidosis patients.
    Z Rheumatol. 2024;83.
    PubMed         Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Rheumatoid Arthritis is free of charge.